CIK 0000879407
- Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460408024
- Phone
- +1 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-09 | McKenney Charles Director | Option exercise · Stock Option (right to buy) | −10,000 | 53,000 | ||
| 2014-02-12 | Myszkowski Kenneth Allen CFO | Option exercise | +16,000 | $2.01 | $32K | 87,500 |
| 2014-02-12 | Myszkowski Kenneth Allen CFO | Sale | −16,000 | $18.77 | $300K | 71,500 |
| 2014-02-12 | Myszkowski Kenneth Allen CFO | Option exercise · Stock Option | −16,000 | 312,000 | ||
| 2014-02-07 | FRYKMAN EDWARD W Director | Option exercise | +5,000 | $10.00 | $50K | 27,000 |
| 2014-02-07 | FRYKMAN EDWARD W Director | Sale | −3,148 | $15.98 | $50K | 23,852 |
| 2014-02-07 | FRYKMAN EDWARD W Director | Option exercise · Stock Option | −5,000 | 77,500 | ||
| 2014-02-06 | FRYKMAN EDWARD W Director | Grant or award | +15,000 | 22,000 | ||
| 2014-02-06 | McKenney Charles Director | Grant or award | +15,000 | 17,220 | ||
| 2014-02-06 | PERRY MICHAEL S Director | Grant or award | +15,000 | 15,000 | ||
| 2014-02-06 | GIVEN DOUGLAS B Director | Grant or award | +20,000 | 20,000 | ||
| 2014-02-06 | GIVEN BRUCE D Chief Operating Officer | Grant or award | +125,000 | 125,000 | ||
| 2014-02-06 | GIVEN BRUCE D Chief Operating Officer | Grant or award · Stock Options | +50,000 | 436,000 | ||
| 2014-02-06 | Anzalone Christopher Richard President and CEO | Grant or award | +210,000 | 244,173 | ||
| 2014-02-06 | Anzalone Christopher Richard President and CEO | Grant or award · Stock Options | +60,000 | 786,466 | ||
| 2014-02-06 | Lewis David L. Chief Scientific Officer | Grant or award · Stock Options | +120,000 | 317,500 | ||
| 2014-02-06 | Myszkowski Kenneth Allen CFO | Grant or award | +70,000 | 71,500 | ||
| 2014-02-06 | Myszkowski Kenneth Allen CFO | Grant or award · Stock Options | +50,000 | 328,000 | ||
| 2014-01-02 | Lewis David L. Chief Scientific Officer | Option exercise | +10,000 | $4.60 | $46K | 10,000 |
| 2014-01-02 | Lewis David L. Chief Scientific Officer | Option exercise | +2,500 | $5.19 | $13K | 12,500 |
Page 40 of 46 · 902 trades